LifeTein, located in Somerset, New Jersey, was founded in 2008 with a simple vision: understanding life one protein at a time. This philosophy has formed the foundation of every peptide, antibody, protein, antibody, and chemical project that we have completed for our customers in the academic, biotechnology, agricultural, government institutions and pharmaceutical fields.
Tuesday, November 11, 2014
LifeTein, the peptide synthesis service company: LifeTein Peptide Cited in Cell
LifeTein, the peptide synthesis service company: LifeTein Peptide Cited in Cell: Peptide library is increasingly used to define antibody epitopes and substrate specificities of protein kinases. For epitope mapping, overla...
LifeTein Peptide Cited in Cell
Peptide library is increasingly used to define antibody epitopes and substrate specificities of protein kinases. For epitope mapping, overlapping peptides are made to span the antigenic protein sequence. The antigenic determinant recognized by a monoclonal antibody can then be screened and defined. The alanine scanning method can also be used to assess that residue’s contribution to antibody binding and to determine which substitutions affect antibody recognition (mutational analysis). Unrelated synthetic peptides can be used to evaluate the antibody cross-reactivity.
Overlapping peptides from LifeTein were used to map the region of Fragment 3 by epitope mapping of anti-Fzd2 antibody. This anti-Fzd2 antibody was found to reduce tumor growth. Wnt signaling plays a critical role in colorectal cancer. Researchers found that Wnt receptor Frizzled2 (Fzd2) and its ligands Wnt5a/b are elevated in metastatic liver, lung, colon, and breast cancer cell lines. Their high level expression correlates with markers of epithelial-mesenchymal transition (EMT). By epitope mapping using synthetic peptides from LifeTein, the researchers mapped the epitope to a specific region. The antibody to Fzd2 was found to reduce cell migration and invasion. Targeting this pathway may provide a cure for patients with tumors expressing high amount of Fzd2 and Wnt5a/b.
We have developed an antibody to Fzd2 that reduces cell migration and invasion and inhibits tumor growth and metastasis in xenografts. We propose that targeting this pathway could provide benefit for patients with tumors expressing high levels of Fzd2 and Wnt5a/b.
Overlapping peptides from LifeTein were used to map the region of Fragment 3 by epitope mapping of anti-Fzd2 antibody. This anti-Fzd2 antibody was found to reduce tumor growth. Wnt signaling plays a critical role in colorectal cancer. Researchers found that Wnt receptor Frizzled2 (Fzd2) and its ligands Wnt5a/b are elevated in metastatic liver, lung, colon, and breast cancer cell lines. Their high level expression correlates with markers of epithelial-mesenchymal transition (EMT). By epitope mapping using synthetic peptides from LifeTein, the researchers mapped the epitope to a specific region. The antibody to Fzd2 was found to reduce cell migration and invasion. Targeting this pathway may provide a cure for patients with tumors expressing high amount of Fzd2 and Wnt5a/b.
We have developed an antibody to Fzd2 that reduces cell migration and invasion and inhibits tumor growth and metastasis in xenografts. We propose that targeting this pathway could provide benefit for patients with tumors expressing high levels of Fzd2 and Wnt5a/b.
- Cell, Volume 159, Issue 4, 6 November 2014, Pages 844–856, DOI: 10.1016/j.cell.2014.10.032 A Noncanonical Frizzled2 Pathway Regulates Epithelial-Mesenchymal Transition and Metastasis
Saturday, November 1, 2014
Synthetic peptide from LifeTein used for drug discovery
Synthetic TAT peptides from LifeTein were used for fluorescence resonance energy transfer (FRET) assay. This arginine-rich TAT peptide contains two fluorophores with FAM at the N terminus and TAMRA at the C terminus.
Three alanines were used as a spacer to avoid potential interference on the binding affinity against TAR. The sequence used in this study is: (5‑FAM)‑ AAARKKRRQRRRAAA-K(TAMRA)‑C.
The Tat peptide causes two fluorophores to form a dimer, quenching the fluorescence of both fluorophores. When the Tat peptide is bound to the bulge of TAR, the peptide transitioned to the extended conformation.
In the study, researchers have identified 11 small molecule inhibitors of TAR‑Tat interaction from high throughput screening (HTS) and virtual screening (VS). One of the compounds showed promising anti‑HIV activity. The hits from HTS and VS suggested that the HTS and VS are complimentary to each other. HTS and VS will boost the efficiency of the drug discovery.
http://scholar.google.com/scholar_url?hl=en&q=http://deepblue.lib.umich.edu/bitstream/handle/2027.42/108771/janghlee_1.pdf%3Fsequence%3D1%26isAllowed%3Dy&sa=X&scisig=AAGBfm20J8EkWT4LD8Rg3mQnJHE7mEZr_w&oi=scholaralrt
Three alanines were used as a spacer to avoid potential interference on the binding affinity against TAR. The sequence used in this study is: (5‑FAM)‑ AAARKKRRQRRRAAA-K(TAMRA)‑C.
The Tat peptide causes two fluorophores to form a dimer, quenching the fluorescence of both fluorophores. When the Tat peptide is bound to the bulge of TAR, the peptide transitioned to the extended conformation.
In the study, researchers have identified 11 small molecule inhibitors of TAR‑Tat interaction from high throughput screening (HTS) and virtual screening (VS). One of the compounds showed promising anti‑HIV activity. The hits from HTS and VS suggested that the HTS and VS are complimentary to each other. HTS and VS will boost the efficiency of the drug discovery.
http://scholar.google.com/scholar_url?hl=en&q=http://deepblue.lib.umich.edu/bitstream/handle/2027.42/108771/janghlee_1.pdf%3Fsequence%3D1%26isAllowed%3Dy&sa=X&scisig=AAGBfm20J8EkWT4LD8Rg3mQnJHE7mEZr_w&oi=scholaralrt
Subscribe to:
Posts (Atom)